| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 91306 |
DOTA-Dglu-(Glu)5-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2的结构组成 |
208 |
wyh |
2024-11-28 |
| 91307 |
polylysine-(Gd-DOTA)的介绍 |
207 |
zyl |
2024-11-28 |
| 91308 |
(R)-DOTAGA-(COOt-Bu)4 817562-90-6 (R)-DOTAGA-四叔丁酯 |
167 |
zcy |
2024-11-28 |
| 91309 |
Azido-mono-amide-DOTA(B-288) |
193 |
zyl |
2024-11-28 |
| 91310 |
DOTA-PEGn-Cys-VS；单分散PEG偶联螯合剂DOTA |
175 |
wyh |
2024-11-28 |
| 91311 |
3-羟基-5-取代芳基吡唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
165 |
WYQ |
2024-11-28 |
| 91312 |
氨基羧酸盐大环NOTA (N(3)O(3)) |
262 |
kx |
2024-11-28 |
| 91313 |
3,6-二对氯苯基-1,4-二氢-S-四嗪-1,4-二对甲基苯砜基 |
154 |
WYQ |
2024-11-28 |
| 91314 |
CAS：437608-50-9 Lutathera |
297 |
zyl |
2024-11-28 |
| 91315 |
3,6-二丙基-N,N'-二甲苯基-1,2,4,5-四嗪-1,4-二甲酰胺 |
167 |
WYQ |
2024-11-28 |
| 91316 |
DOTA-PEGn-Cys-VS；单分散PEG偶联螯合剂DOTA |
144 |
wyh |
2024-11-28 |
| 91317 |
3,6-二胺基-1,2,4,5-四嗪(DAT) |
203 |
WYQ |
2024-11-28 |
| 91318 |
CAS：2057438-24-9 Dotatate tfa |
201 |
zyl |
2024-11-28 |
| 91319 |
3，6-二(对氯苄基)-s-四嗪 |
146 |
WYQ |
2024-11-28 |
| 91320 |
DOTA-cBR96 ， DOTA偶联BR96单克隆抗体 |
178 |
kx |
2024-11-28 |
| 91321 |
p-NH2-Bn-DOTA-hu14.18K322A |
302 |
wyh |
2024-11-28 |
| 91322 |
3，6-二(对氯苯基)-s-四嗪 |
168 |
WYQ |
2024-11-28 |
| 91323 |
DOTA-tri(acid)-amido-PEG3-Bromoacetamide 定制 |
160 |
zcy |
2024-11-28 |
| 91324 |
CAS：306776-79-4 DOTAGA-tetra (t-Bu ester) |
195 |
zyl |
2024-11-28 |
| 91325 |
N,N'-二取代基-3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酰胺类化合物 |
171 |
WYQ |
2024-11-28 |
| 91326 |
DOTA-ZHER2:2891-Affibody |
308 |
wyh |
2024-11-28 |
| 91327 |
CAS：872469-60-8 大环化合物 |
153 |
zyl |
2024-11-28 |
| 91328 |
1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸(DOTA)共轭GnRH肽 |
132 |
kx |
2024-11-28 |
| 91329 |
3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酸甲酯化合物 |
148 |
WYQ |
2024-11-28 |
| 91330 |
3-氧代-5-取代芳基异唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
163 |
WYQ |
2024-11-28 |
| 91331 |
cas:619300-53-7 DOTA-NOC；DOTA-Nal3-octreotide |
141 |
zcy |
2024-11-28 |
| 91332 |
CAS：157599-02-5 1,4,7,10-四(氨基羰甲基)-1,4,7,10-四氮杂环十二烷 |
130 |
zyl |
2024-11-28 |
| 91333 |
DOTA-peptide-(GGGF)-m170的结构组成 |
248 |
wyh |
2024-11-28 |
| 91334 |
DOTA-3P-RGD ，双功能螯合剂DOTA偶联环肽RGD二聚体 |
252 |
kx |
2024-11-28 |
| 91335 |
CAS：913542-71-9 DOTA di(tBu)ester |
136 |
zyl |
2024-11-28 |
| 91336 |
cas: 1192362-32-5 DOTA-LM3 |
169 |
zcy |
2024-11-28 |
| 91337 |
DOPE-PEG-DOTA 磷脂-聚乙二醇-大环配体 |
155 |
zyl |
2024-11-28 |
| 91338 |
DOTA-GX1 ， 大环螯合剂DOTA缀合GX1肽 |
138 |
kx |
2024-11-28 |
| 91339 |
甲氧基DOTA；MeO-DOTA |
452 |
wyh |
2024-11-28 |
| 91340 |
cas:865470-67-3 DOTA-Thiol |
160 |
zcy |
2024-11-28 |
| 91341 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-烷基酮 |
152 |
WYQ |
2024-11-28 |
| 91342 |
DOTA-tris(acid)-amido-dPEG-TFP ester |
140 |
zyl |
2024-11-28 |
| 91343 |
DOTA-赖氨酸(DOTA-L) |
196 |
kx |
2024-11-28 |
| 91344 |
p-NH2-benzyl-NOTA； p-NH2-苄基-NOTA缀合物 |
132 |
wyh |
2024-11-28 |
| 91345 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-甲酸酯 |
120 |
WYQ |
2024-11-28 |
| 91346 |
cas:1908409-18-6 DOTA Zoledronate DOTA唑来膦酸盐 |
174 |
zcy |
2024-11-28 |
| 91347 |
CAS：177943-88-3 DOTATATE |
150 |
zyl |
2024-11-28 |
| 91348 |
钆-四氮杂环十二烷-四乙酸 ， LPS+Gd-DOTA |
163 |
kx |
2024-11-28 |
| 91349 |
N-取代苯基-3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-甲酰胺 |
233 |
WYQ |
2024-11-28 |
| 91350 |
DOTA-RM2；胃泌素释放肽受体的示踪剂 |
172 |
wyh |
2024-11-28 |
齐岳微信公众号
官方微信
库存查询